Preconditioning-induced ischemic tolerance: A window into endogenous gearing for cerebroprotection

Experimental and Translational Stroke Medicine

Volumn 2, Issue 1, 2010, Pages

  Durukan, Aysan ^a   Tatlisumak, Turgut ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANESTHETIC AGENT; CALCIUM; ERYTHROMYCIN; ERYTHROPOIETIN; ESTROGEN; HALOTHANE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1; ISOFLURANE; KANAMYCIN; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; PROTEIN KINASE C; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA; XENON;

ADAPTATION; APOPTOSIS; BRAIN HYPOXIA; BRAIN ISCHEMIA; DISEASE MODEL; DNA MICROARRAY; FUNCTIONAL ASSESSMENT; GENE ACTIVATION; GENOMICS; HISTOLOGY; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIA; HYPOTENSION; HYPOTHERMIA; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SPREADING CORTICAL DEPRESSION; STIMULUS; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 77953225083     PISSN: None     EISSN: 20407378     Source Type: Journal    
DOI: 10.1186/2040-7378-2-2     Document Type: Review

References (242)

1. Dahl NA, Balfour WM. Prolonged anoxic survival due to anoxia pre-exposure: Brain ATP, lactate, and pyruvate. Am J Physiol 1964, 207:452-456.
2. Wells BA, Keats AS, Cooley DA. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 1963, 54:216-223.
3. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990, 528:21-24. 10.1016/0006-8993(90)90189-I, 2245337.
4. Koerner IP, Alkayed NJ. Ischemic preconditioning. Acute stroke, bench to bedside 2006, 345-353. New York: Informa Helthcare, Bhardwaj A, Alkayed NJ, Kirsch JR, Traystman RJ.
5. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006, 7:437-448. 10.1038/nrn1927, 16715053.
6. Zhang J, Yang ZJ, Klaus JA, Koehler RC, Huang J. Delayed tolerance with repetitive transient focal ischemic preconditioning in the mouse. Stroke 2008, 39:967-974. 10.1161/STROKEAHA.107.497412, 2396183, 18239169.
7. Abe H, Nowak TS. Induced hippocampal neuron protection in an optimized gerbil ischemia model: insult thresholds for tolerance induction and altered gene expression defined by ischemic depolarization. J Cereb Blood Flow Metab 2004, 24:84-97. 10.1097/01.WCB.0000098607.42140.4B, 14688620.
8. Perez-Pinzon MA, Basit A, Dave KR, Busto R, Veauvy C, Saul I, Ginsberg MD, Sick TJ. Effect of the first window of ischemic preconditioning on mitochondrial dysfunction following global cerebral ischemia. Mitochondrion 2002, 2:181-189. 10.1016/S1567-7249(02)00070-3, 16120319.
9. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002, 22:1283-1296. 10.1097/00004647-200211000-00001, 12439285.
10. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50:307-320. 10.1002/glia.20204, 15846804.
11. Perez-Pinzon MA. Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg Biomembr 2004, 36:323-327. 10.1023/B:JOBB.0000041762.47544.ff, 15377866.
12. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10:267-272.
13. Pulsinelli WA, Duffy TE. Regional energy balance in rat brain after transient forebrain ischemia. J Neurochem 1983, 40:1500-1503.
14. Schmidt-Kastner R, Paschen W, Ophoff BG, Hossmann KA. A modified four-vessel occlusion model for inducing incomplete forebrain ischemia in rats. Stroke 1989, 20:938-946.
15. Choi JS, Kim HY, Cha JH, Lee MY. Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 2006, 409:187-191. 10.1016/j.neulet.2006.09.053, 17029782.
16. Danielisova V, Gottlieb M, Nemethova M, Burda J. The effect of preconditioning on the iron deposition after transient forebrain ischemia in rat brain. Arch Ital Biol 2004, 142:87-94.
17. Zhang QG, Han D, Xu J, Lv Q, Wang R, Yin XH, Xu TL, Zhang GY. Ischemic preconditioning negatively regulates plenty of SH3s-mixed lineage kinase 3-Rac1 complex and c-Jun N-terminal kinase 3 signaling via activation of Akt. Neuroscience 2006, 143:431-444. 10.1016/j.neuroscience.2006.07.049, 16973299.
18. Burda J, Hrehorovska M, Bonilla LG, Danielisova V, Cizkova D, Burda R, Nemethova M, Fando JL, Salinas M. Role of protein synthesis in the ischemic tolerance acquisition induced by transient forebrain ischemia in the rat. Neurochem Res 2003, 28:1213-1219. 10.1023/A:1024232513106, 12834261.
19. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 1984, 69:385-401. 10.1111/j.1600-0404.1984.tb07822.x, 6464670.
20. Thaddeus NS. Animal models of global cerebral ischemia. Acute stroke, bench to bedside 2006, 275-292. New York: Informa Healthcare, Bhardwaj A, Alkayed NJ, Kirsch JR, Traystman RJ.
21. Dave KR, Lange-Asschenfeldt C, Raval AP, Prado R, Busto R, Saul I, Perez-Pinzon MA. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res 2005, 82:665-673. 10.1002/jnr.20674, 16247804.
22. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Chan PH. Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. J Cereb Blood Flow Metab 2003, 23:949-961. 10.1097/01.WCB.0000077641.41248.EA, 12902839.
23. Liu C, Chen S, Kamme F, Hu BR. Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia. Neuroscience 2005, 134:69-80. 10.1016/j.neuroscience.2005.03.036, 15939539.
24. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 1997, 17:175-182. 10.1097/00004647-199702000-00007, 9040497.
25. Tatlisumak T, Li F, Fisher M. Animal models of ischemic stroke. Acute stroke, bench to bedside 2006, 171-186. New York: Informa Healthcare, Bhardwaj A, Alkayed NJ, Kirsch JR, Traystman RJ.
26. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982, 239:57-69. 10.1016/0006-8993(82)90833-2, 7093691.
27. Kato H, Liu Y, Araki T, Kogure K. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res 1991, 553:238-242. 10.1016/0006-8993(91)90831-F, 1933283.
28. Kirino T, Tsujita Y, Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab 1991, 11:299-307.
29. Kato H, Kogure K, Nakata N, Araki T, Itoyama Y. Facilitated recovery from postischemic suppression of protein synthesis in the gerbil brain with ischemic tolerance. Brain Res Bull 1995, 36:205-208. 10.1016/0361-9230(94)00191-3, 7895099.
30. Corbett D, Crooks P. Ischemic preconditioning: a long term survival study using behavioural and histological endpoints. Brain Res 1997, 760:129-136. 10.1016/S0006-8993(97)00294-1, 9237527.
31. Castro-Pacheco A, Foyo-Niembro E, Perez-Perez V, Garcia-Hernandez J, Grijalva I. [Carotid-basilar artery communication in gerbils (Meriones unguiculatus)]. Rev Neurol 2001, 32:225-228.
32. Ueda M, Nowak TS. Protective preconditioning by transient global ischemia in the rat: components of delayed injury progression and lasting protection distinguished by comparisons of depolarization thresholds for cell loss at long survival times. J Cereb Blood Flow Metab 2005, 25:949-958. 10.1038/sj.jcbfm.9600107, 15758943.
33. Terashima T, Namura S, Hoshimaru M, Uemura Y, Kikuchi H, Hashimoto N. Consistent injury in the striatum of C57BL/6 mice after transient bilateral common carotid artery occlusion. Neurosurgery 1998, 43:900-907. 10.1097/00006123-199810000-00102, 9766318.
34. Wu C, Zhan RZ, Qi S, Fujihara H, Taga K, Shimoji K. A forebrain ischemic preconditioning model established in C57Black/Crj6 mice. J Neurosci Methods 2001, 107:101-106. 10.1016/S0165-0270(01)00356-9, 11389947.
35. Munoz A, Nakazaki M, Goodman JC, Barrios R, Onetti CG, Bryan J, Aguilar-Bryan L. Ischemic preconditioning in the hippocampus of a knockout mouse lacking SUR1-based K(ATP) channels. Stroke 2003, 34:164-170. 10.1161/01.STR.0000048215.36747.D1, 12511769.
36. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986, 8:1-8.
37. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
38. Takano K, Tatlisumak T, Bergmann AG, Gibson DG, Fisher M. Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci 1997, 153:8-11. 10.1016/S0022-510X(97)00184-6, 9455971.
39. Tatlisumak T, Carano RA, Takano K, Opgenorth TJ, Sotak CH, Fisher M. A novel endothelin antagonist, A-12 attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 7722, 29:850-857.
40. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007, 87:179-197. 10.1016/j.pbb.2007.04.015, 17521716.
41. Durukan A, Strbian D, Tatlisumak T. Rodent models of ischemic stroke: a useful tool for stroke drug development. Curr Pharm Des 2008, 14:359-370. 10.2174/138161208783497688, 18289062.
42. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885. 10.1126/science.7522345, 7522345.
43. Li J, Henman MC, Doyle KM, Strbian D, Kirby BP, Tatlisumak T, Shaw GG. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice. Brain Res 2004, 1029:84-92. 10.1016/j.brainres.2004.09.037, 15533319.
44. Li J, Henman MC, Tatlisumak T, Shaw GG, Doyle KM. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice. Brain Res 2005, 1055:180-185. 10.1016/j.brainres.2005.07.023, 16095573.
45. Li J, Henman MC, Atkinson J, Fixon-Owoo S, Tatlisumak T, Shaw GG, Doyle KM. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice. Brain Res 2006, 1076:209-215. 10.1016/j.brainres.2005.12.097, 16473330.
46. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, Feuerstein GZ. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 1998, 29:1937-1950.
47. Masada T, Hua Y, Xi G, Ennis SR, Keep RF. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J Cereb Blood Flow Metab 2001, 21:22-33. 10.1097/00004647-200101000-00004, 11149665.
48. Pradillo JM, Romera C, Hurtado O, Cardenas A, Moro MA, Leza JC, Davalos A, Castillo J, Lorenzo P, Lizasoain I. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab 2005, 25:193-203. 10.1038/sj.jcbfm.9600019, 15647744.
49. Stagliano NE, Perez-Pinzon MA, Moskowitz MA, Huang PL. Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 1999, 19:757-761. 10.1097/00004647-199907000-00005, 10413030.
50. Atochin DN, Clark J, Demchenko IT, Moskowitz MA, Huang PL. Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke 2003, 34:1299-1303. 10.1161/01.STR.0000066870.70976.57, 12677017.
51. Hao Y, Luo Z, Zhou D, Gao L. Cerebral ischemic tolerance induced by focal ischemic preconditioning in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2003, 34:455-458.
52. Lee SH, Kim YJ, Lee KM, Ryu S, Yoon BW. Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience 2007, 146:1020-1031. 10.1016/j.neuroscience.2007.02.058, 17434685.
53. Alkayed NJ, Goyagi T, Joh HD, Klaus J, Harder DR, Traystman RJ, Hurn PD. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 2002, 33:1677-1684. 10.1161/01.STR.0000016332.37292.59, 12053011.
54. Chen J, Graham SH, Zhu RL, Simon RP. Stress proteins and tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 1996, 16:566-577. 10.1097/00004647-199607000-00006, 8964795.
55. Li W, Luo Y, Zhang F, Signore AP, Gobbel GT, Simon RP, Chen J. Ischemic preconditioning in the rat brain enhances the repair of endogenous oxidative DNA damage by activating the base-excision repair pathway. J Cereb Blood Flow Metab 2006, 26:181-198. 10.1038/sj.jcbfm.9600180, 16001017.
56. Glantz L, Avramovich A, Trembovler V, Gurvitz V, Kohen R, Eidelman LA, Shohami E. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp Neurol 2005, 192:117-124. 10.1016/j.expneurol.2004.11.012, 15698625.
57. Puisieux F, Deplanque D, Bulckaen H, Maboudou P, Gele P, Lhermitte M, Lebuffe G, Bordet R. Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidase. Brain Res 2004, 1027:30-37. 10.1016/j.brainres.2004.08.067, 15494154.
58. Hoyte LC, Papadakis M, Barber PA, Buchan AM. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res 2006, 1121:231-237. 10.1016/j.brainres.2006.08.107, 17010948.
59. Naylor M, Bowen KK, Sailor KA, Dempsey RJ, Vemuganti R. Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus. Neurochem Int 2005, 47:565-572. 10.1016/j.neuint.2005.07.003, 16154234.
60. Simon RP, Niiro M, Gwinn R. Prior ischemic stress protects against experimental stroke. Neurosci Lett 1993, 163:135-137. 10.1016/0304-3940(93)90364-Q, 8309618.
61. Matsushima K, Hakim AM. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion. Stroke 1995, 26:1047-1052.
62. Miyashita K, Abe H, Nakajima T, Ishikawa A, Nishiura M, Sawada T, Naritomi H. Induction of ischaemic tolerance in gerbil hippocampus by pretreatment with focal ischaemia. Neuroreport 1994, 6:46-48. 10.1097/00001756-199412300-00013, 7703426.
63. Belayev L, Ginsberg MD, Alonso OF, Singer JT, Zhao W, Busto R. Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: relationship to c-fos mRNA expression. Neuroreport 1996, 8:55-59. 10.1097/00001756-199612200-00012, 9051752.
64. Glazier SS, O'Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief focal ischemia in rat brain. J Cereb Blood Flow Metab 1994, 14:545-553.
65. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994, 168:221-224. 10.1016/0304-3940(94)90455-3, 8028780.
66. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001, 12:1663-1669. 10.1097/00001756-200106130-00030, 11409736.
67. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002, 22:393-403. 10.1097/00004647-200204000-00003, 11919510.
68. Wada K, Ito M, Miyazawa T, Katoh H, Nawashiro H, Shima K, Chigasaki H. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res 1996, 740:15-20. 10.1016/S0006-8993(96)00831-1, 8973793.
69. Prass K, Wiegand F, Schumann P, Ahrens M, Kapinya K, Harms C, Liao W, Trendelenburg G, Gertz K, Moskowitz MA, Knapp F, Victorov IV, Megow D, Dirnagl U. Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Res 2000, 871:146-150. 10.1016/S0006-8993(00)02264-2, 10882793.
70. Xiong L, Zhu Z, Dong H, Hu W, Hou L, Chen S. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model. Chin Med J (Engl) 2000, 113:836-839.
71. Hirata T, Cui YJ, Funakoshi T, Mizukami Y, Ishikawa Y, Shibasaki F, Matsumoto M, Sakabe T. The temporal profile of genomic responses and protein synthesis in ischemic tolerance of the rat brain induced by repeated hyperbaric oxygen. Brain Res 2007, 1130:214-222. 10.1016/j.brainres.2006.10.077, 17173873.
72. Chopp M, Chen H, Ho KL, Dereski MO, Brown E, Hetzel FW, Welch KM. Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurology 1989, 39:1396-1398.
73. Ikeda T, Xia XY, Xia YX, Ikenoue T. Hyperthermic preconditioning prevents blood-brain barrier disruption produced by hypoxia-ischemia in newborn rat. Brain Res Dev Brain Res 1999, 117:53-58. 10.1016/S0165-3806(99)00097-8, 10536232.
74. Nishio S, Chen ZF, Yunoki M, Toyoda T, Anzivino M, Lee KS. Hypothermia-induced ischemic tolerance. Ann N Y Acad Sci 1999, 890:26-41. 10.1111/j.1749-6632.1999.tb07978.x, 10668411.
75. Yunoki M, Nishio S, Ukita N, Anzivino MJ, Lee KS. Characteristics of hypothermic preconditioning influencing the induction of delayed ischemic tolerance. J Neurosurg 2002, 97:650-657. 10.3171/jns.2002.97.3.0650, 12296650.
76. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998, 29:2461-2466.
77. Tatlisumak T, Takano K, Meiler MR, Fisher M. A glycine site antagonist, ZD reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Stroke 9379, 29:190-195.
78. Jander S, Schroeter M, Peters O, Witte OW, Stoll G. Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab 2001, 21:218-225. 10.1097/00004647-200103000-00005, 11295876.
79. Kawahara N, Ruetzler CA, Klatzo I. Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol Res 1995, 17:9-16.
80. Matsushima K, Hogan MJ, Hakim AM. Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1996, 16:221-226. 10.1097/00004647-199603000-00006, 8594053.
81. Horiguchi T, Snipes JA, Kis B, Shimizu K, Busija DW. The role of nitric oxide in the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Brain Res 2005, 1039:84-89. 10.1016/j.brainres.2005.01.047, 15781049.
82. Otori T, Greenberg JH, Welsh FA. Cortical spreading depression causes a long-lasting decrease in cerebral blood flow and induces tolerance to permanent focal ischemia in rat brain. J Cereb Blood Flow Metab 2003, 23:43-50. 10.1097/00004647-200301000-00005, 12500090.
83. Horiguchi T, Snipes JA, Kis B, Shimizu K, Busija DW. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Neuroscience 2006, 140:723-730. 10.1016/j.neuroscience.2006.02.025, 16567054.
84. Yanamoto H, Xue JH, Miyamoto S, Nagata I, Nakano Y, Murao K, Kikuchi H. Spreading depression induces long-lasting brain protection against infarcted lesion development via BDNF gene-dependent mechanism. Brain Res 2004, 1019:178-188. 10.1016/j.brainres.2004.05.105, 15306252.
85. Yanamoto H, Hashimoto N, Nagata I, Kikuchi H. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res 1998, 784:239-249. 10.1016/S0006-8993(97)01344-9, 9518633.
86. Sun XC, Li WB, Li QJ, Zhang M, Xian XH, Qi J, Jin RL, Li SQ. Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK. Brain Res 2006, 1084:165-174. 10.1016/j.brainres.2006.02.041, 16631139.
87. Zhao HG, Sun XC, Xian XH, Li WB, Zhang M, Li QJ. The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats. Neurochem Res 2007, 32:1919-1926. 10.1007/s11064-007-9381-2, 17551830.
88. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007, 116:I98-105. 10.1161/circulationaha.106.679167, 17846333.
89. Rehni AK, Shri R, Singh M. Remote ischaemic preconditioning and prevention of cerebral injury. Indian J Exp Biol 2007, 45:247-252.
90. Wiegand F, Liao W, Busch C, Castell S, Knapp F, Lindauer U, Megow D, Meisel A, Redetzky A, Ruscher K, Trendelenburg G, Victorov I, Riepe M, Diener HC, Dirnagl U. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 1999, 19:1229-1237. 10.1097/00004647-199911000-00007, 10566969.
91. Zhu HC, Gao XQ, Xing Y, Sun SG, Li HG, Wang YF. Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. J Mol Neurosci 2004, 24:299-305. 10.1385/JMN:24:2:299, 15456943.
92. Zhu H, Sun S, Li H, Xu Y. Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats. J Huazhong Univ Sci Technolog Med Sci 2006, 26:440-443. 10.1007/s11596-006-0416-8, 17120743.
93. Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 2003, 34:1015-1020. 10.1161/01.STR.0000063404.27912.5B, 12649508.
94. Garnier P, Bertrand N, Demougeot C, Prigent-Tessier A, Marie C, Beley A. Chemical preconditioning with 3-nitropropionic acid: lack of induction of neuronal tolerance in gerbil hippocampus subjected to transient forebrain ischemia. Brain Res Bull 2002, 58:33-39. 10.1016/S0361-9230(02)00753-0, 12121810.
95. Sugino T, Nozaki K, Takagi Y, Hashimoto N. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci Lett 1999, 259:9-12. 10.1016/S0304-3940(98)00875-1, 10027543.
96. Kato K, Shimazaki K, Kamiya T, Amemiya S, Inaba T, Oguro K, Katayama Y. Differential effects of sublethal ischemia and chemical preconditioning with 3-nitropropionic acid on protein expression in gerbil hippocampus. Life Sci 2005, 77:2867-2878. 10.1016/j.lfs.2005.01.037, 15961120.
97. Hoshi A, Nakahara T, Ogata M, Yamamoto T. The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat. Brain Res 2005, 1050:33-39. 10.1016/j.brainres.2005.05.028, 15961068.
98. Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, Martin A, Bastide M, Leys D, Lhermitte M, Dupuis B. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab 2000, 20:1190-1196. 10.1097/00004647-200008000-00004, 10950379.
99. Bastide M, Gele P, Petrault O, Pu Q, Caliez A, Robin E, Deplanque D, Duriez P, Bordet R. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J Cereb Blood Flow Metab 2003, 23:399-405. 10.1097/00004647-200304000-00003, 12679716.
100. Dawson DA, Furuya K, Gotoh J, Nakao Y, Hallenbeck JM. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J Cereb Blood Flow Metab 1999, 19:616-623. 10.1097/00004647-199906000-00004, 10366191.
101. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 1997, 748:267-270. 10.1016/S0006-8993(96)01383-2, 9067475.
102. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 2004, 35:2576-2581. 10.1161/01.STR.0000143450.04438.ae, 15375302.
103. Wang L, Traystman RJ, Murphy SJ. Inhalational anesthetics as preconditioning agents in ischemic brain. Curr Opin Pharmacol 2008, 8:104-110. 10.1016/j.coph.2007.09.005, 2254937, 17962069.
104. Kitano H, Kirsch JR, Hurn PD, Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007, 27:1108-1128. 10.1038/sj.jcbfm.9600410, 2266688, 17047683.
105. Clarkson AN. Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci 2007, 80:1157-1175. 10.1016/j.lfs.2006.12.022, 17258776.
106. Blanck TJ, Haile M, Xu F, Zhang J, Heerdt P, Veselis RA, Beckman J, Kang R, Adamo A, Hemmings H. Isoflurane pretreatment ameliorates postischemic neurologic dysfunction and preserves hippocampal Ca2+/calmodulin-dependent protein kinase in a canine cardiac arrest model. Anesthesiology 2000, 93:1285-1293. 10.1097/00000542-200011000-00023, 11046218.
107. Liu Y, Xiong L, Chen S, Wang Q. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth 2006, 53:194-201. 10.1007/BF03021827, 16434762.
108. Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 2004, 65:1172-1180. 10.1124/mol.65.5.1172, 15102945.
109. McAuliffe JJ, Joseph B, Vorhees CV. Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth Analg 2007, 104:1066-1077. 10.1213/01.ane.0000260321.62377.74, 17456654.
110. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003, 118:99-106. 10.1016/S0306-4522(02)00767-4, 12676141.
111. Kaneko T, Yokoyama K, Makita K. Late preconditioning with isoflurane in cultured rat cortical neurones. Br J Anaesth 2005, 95:662-668. 10.1093/bja/aei228, 16143577.
112. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006, 26:199-208. 10.1038/sj.jcbfm.9600184, 16034370.
113. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002, 33:1889-1898. 10.1161/01.STR.0000020092.41820.58, 12105371.
114. Payne RS, Akca O, Roewer N, Schurr A, Kehl F. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 2005, 1034:147-152. 10.1016/j.brainres.2004.12.006, 15713266.
115. Frassdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T, Weber R, Mullenheim J, Weber NC, Preckel B, Schlack W. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 2009, 137:1436-1442. 10.1016/j.jtcvs.2008.04.034, 19464461.
116. Raval AP, Bramlett H, Perez-Pinzon MA. Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience 2006, 141:1721-1730. 10.1016/j.neuroscience.2006.05.016, 16777351.
117. Brambrink AM, Koerner IP, Diehl K, Strobel G, Noppens R, Kempski O. The antibiotic erythromycin induces tolerance against transient global cerebral ischemia in rats (pharmacologic preconditioning). Anesthesiology 2006, 104:1208-1215. 10.1097/00000542-200606000-00016, 16732092.
118. Koerner IP, Gatting M, Noppens R, Kempski O, Brambrink AM. Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation. Anesthesiology 2007, 106:538-547. 10.1097/00000542-200703000-00019, 17325513.
119. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002, 22:10291-10301.
120. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999, 19:643-651. 10.1097/00004647-199906000-00007, 10366194.
121. Riepe MW, Kasischke K, Raupach A. Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke 1997, 28:2006-2011.
122. Huber R, Kasischke K, Ludolph AC, Riepe MW. Increase of cellular hypoxic tolerance by erythromycin and other antibiotics. Neuroreport 1999, 10:1543-1546. 10.1097/00001756-199905140-00027, 10380977.
123. Xiong L, Lu Z, Hou L, Zheng H, Zhu Z, Wang Q, Chen S. Pretreatment with repeated electroacupuncture attenuates transient focal cerebral ischemic injury in rats. Chin Med J (Engl) 2003, 116:108-111.
124. Xiong LZ, Yang J, Wang Q, Lu ZH. Involvement of delta-and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats. Chin Med J (Engl) 2007, 120:394-399.
125. Reis DJ, Kobylarz K, Yamamoto S, Golanov EV. Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection. Brain Res 1998, 780:161-165. 10.1016/S0006-8993(97)01017-2, 9497093.
126. Yu ZF, Mattson MP. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 1999, 57:830-839. 10.1002/(SICI)1097-4547(19990915)57:6<830::AID-JNR8>3.0.CO;2-2, 10467254.
127. Ogiue-Ikeda M, Kawato S, Ueno S. Acquisition of ischemic tolerance by repetitive transcranial magnetic stimulation in the rat hippocampus. Brain Res 2005, 1037:7-11. 10.1016/j.brainres.2004.10.063, 15777747.
128. Mishima Y, Harada H, Sugiyama K, Miyagawa Y, Uehara N, Kano T. Induction of neuronal tolerance by electroconvulsive shock in rats subjected to forebrain ischemia. Kurume Med J 2005, 52:153-160. 10.2739/kurumemedj.52.153, 16639987.
129. Plamondon H, Blondeau N, Heurteaux C, Lazdunski M. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J Cereb Blood Flow Metab 1999, 19:1296-1308. 10.1097/00004647-199912000-00002, 10598933.
130. Hsu JC, Lee YS, Chang CN, Ling EA, Lan CT. Sleep deprivation prior to transient global cerebral ischemia attenuates glial reaction in the rat hippocampal formation. Brain Res 2003, 984:170-181. 10.1016/S0006-8993(03)03128-7, 12932851.
131. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, Dawson VL. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 2000, 97:436-441. 10.1073/pnas.97.1.436, 26681, 10618436.
132. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993, 13:3510-3524.
133. Kapinya KJ. Ischemic tolerance in the brain. Acta Physiol Hung 2005, 92:67-92. 10.1556/APhysiol.92.2005.1.9, 16003947.
134. Valentim LM, Rodnight R, Geyer AB, Horn AP, Tavares A, Cimarosti H, Netto CA, Salbego CG. Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 2003, 118:379-386. 10.1016/S0306-4522(02)00919-3, 12699774.
135. Hassen GW, Tian D, Ding D, Bergold PJ. A new model of ischemic preconditioning using young adult hippocampal slice cultures. Brain Res Brain Res Protoc 2004, 13:135-143. 10.1016/j.brainresprot.2004.03.004, 15296850.
136. Grabb MC, Choi DW. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci 1999, 19:1657-1662.
137. Sommer C. Ischemic preconditioning: postischemic structural changes in the brain. J Neuropathol Exp Neurol 2008, 67:85-92. 10.1097/nen.0b013e3181630ba6, 18219260.
138. Corbett D, Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol 1998, 54:531-548. 10.1016/S0301-0082(97)00078-6, 9550190.
139. Tatlisumak T, Takano K, Carano RA, Fisher M. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke 1996, 27:2292-2297.
140. Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 1998, 50:870-875.
141. Tanaka H, Calderone A, Jover T, Grooms SY, Yokota H, Zukin RS, Bennett MV. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1. Proc Natl Acad Sci USA 2002, 99:2362-2367. 122370, 11842229.
142. Ostrowski RP, Graupner G, Titova E, Zhang J, Chiu J, Dach N, Corleone D, Tang J, Zhang JH. The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol Dis 2007, 29:1-13. 10.1016/j.nbd.2007.07.020, 2190110, 17822911.
143. Kim E, Raval AP, Defazio RA, Perez-Pinzon MA. Ischemic preconditioning via epsilon protein kinase C activation requires cyclooxygenase-2 activation in vitro. Neuroscience 2007, 145:931-941. 10.1016/j.neuroscience.2006.12.063, 2153455, 17307294.
144. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106. 10.1097/00006123-199207000-00014, 1641086.
145. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000, 39:806-816. 10.1016/S0028-3908(99)00262-2, 10699446.
146. Nunn J, Hodges H. Cognitive deficits induced by global cerebral ischaemia: relationship to brain damage and reversal by transplants. Behav Brain Res 1994, 65:1-31. 10.1016/0166-4328(94)90069-8, 7880447.
147. Tatlisumak T, Li F. Use of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke. Curr Drug Targets CNS Neurol Disord 2003, 2:131-141. 10.2174/1568007033482968, 12769805.
148. Tatlisumak T, Strbian D, Abo Ramadan U, Li F. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics. Curr Vasc Pharmacol 2004, 2:343-355. 10.2174/1570161043385493, 15320814.
149. Durukan A, Tatlisumak T. Magnetic resonance imaging in drug development for ischemic stroke: a translational approach. Drug Design Research Perspectives 2007, 171-211. NY: Nova Science Pub Inc, Kaplan SP.
150. Strbian D, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, Abo-Ramadan U, Tatlisumak T. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008, 153:175-181. 10.1016/j.neuroscience.2008.02.012, 18367342.
151. Durukan A, Marinkovic I, Strbian D, Pitkonen M, Pedrono E, Soinne L, Abo-Ramadan U, Tatlisumak T. Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI. Brain Res 2009, 1280:158-165. 10.1016/j.brainres.2009.05.025, 19450568.
152. Mullins PG, Reid DG, Hockings PD, Hadingham SJ, Campbell CA, Chalk JB, Doddrell DM. Ischaemic preconditioning in the rat brain: a longitudinal magnetic resonance imaging (MRI) study. NMR Biomed 2001, 14:204-209. 10.1002/nbm.703, 11357186.
153. Tatlisumak T, Carano RA, Takano K, Meiler MR, Li F, Sotak CH, Arndts D, Pschorn U, Fisher M. Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat. J Neurol Sci 2000, 178:107-113. 10.1016/S0022-510X(00)00380-4, 11018702.
154. Carano RA, Li F, Irie K, Helmer KG, Silva MD, Fisher M, Sotak CH. Multispectral analysis of the temporal evolution of cerebral ischemia in the rat brain. J Magn Reson Imaging 2000, 12:842-858. 10.1002/1522-2586(200012)12:6<842::AID-JMRI7>3.0.CO;2-5, 11105022.
155. Li F, Carano RA, Irie K, Tatlisumak T, Silva MD, Pschorni U, Sotak CH, Fisher M. Neuroprotective effects of a novel broad-spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: a multispectral study. J Magn Reson Imaging 1999, 10:138-145. 10.1002/(SICI)1522-2586(199908)10:2<138::AID-JMRI5>3.0.CO;2-G, 10441016.
156. Furuya K, Zhu L, Kawahara N, Abe O, Kirino T. Differences in infarct evolution between lipopolysaccharide-induced tolerant and nontolerant conditions to focal cerebral ischemia. J Neurosurg 2005, 103:715-723. 10.3171/jns.2005.103.4.0715, 16266055.
157. Gustavsson M, Wilson MA, Mallard C, Rousset C, Johnston MV, Hagberg H. Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms?. Pediatr Res 2007, 61:444-450. 10.1203/pdr.0b013e3180332be4, 17515869.
158. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 2004, 89:73-89. 10.1111/j.1471-4159.2004.02316.x, 15030391.
159. Kato H, Araki T, Kogure K. Preserved neurotransmitter receptor binding following ischemia in preconditioned gerbil brain. Brain Res Bull 1992, 29:395-400. 10.1016/0361-9230(92)90074-8, 1327423.
160. Sommer C, Fahrner A, Kiessling M. [3H]muscimol binding to gamma-aminobutyric acid(A) receptors is upregulated in CA1 neurons of the gerbil hippocampus in the ischemia-tolerant state. Stroke 2002, 33:1698-1705. 10.1161/01.STR.0000016404.14407.77, 12053014.
161. Nakagomi T, Kirino T, Kanemitsu H, Tsujita Y, Tamura A. Early recovery of protein synthesis following ischemia in hippocampal neurons with induced tolerance in the gerbil. Acta Neuropathol 1993, 86:10-15. 10.1007/BF00454892, 8372636.
162. Nishimura M, Sugino T, Nozaki K, Takagi Y, Hattori I, Hayashi J, Hashimoto N, Moriguchi T, Nishida E. Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance. J Cereb Blood Flow Metab 2003, 23:1052-1059. 10.1097/01.WCB.0000084251.20114.65, 12973021.
163. Cho S, Park EM, Zhou P, Frys K, Ross ME, Iadecola C. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J Cereb Blood Flow Metab 2005, 25:493-501. 10.1038/sj.jcbfm.9600058, 15689953.
164. Kunz A, Park L, Abe T, Gallo EF, Anrather J, Zhou P, Iadecola C. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J Neurosci 2007, 27:7083-7093. 10.1523/JNEUROSCI.1645-07.2007, 17611261.
165. Gidday JM, Shah AR, Maceren RG, Wang Q, Pelligrino DA, Holtzman DM, Park TS. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 1999, 19:331-340. 10.1097/00004647-199903000-00011, 10078885.
166. Centeno JM, Orti M, Salom JB, Sick TJ, Perez-Pinzon MA. Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices. Brain Res 1999, 836:62-69. 10.1016/S0006-8993(99)01610-8, 10415405.
167. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003, 26:248-254. 10.1016/S0166-2236(03)00071-7, 12744841.
168. Dirnagl U, Meisel A. Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology 2008, 55:334-344. 10.1016/j.neuropharm.2008.02.017, 18402985.
169. Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 2008, 88:211-247. 10.1152/physrev.00039.2006, 18195087.
170. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000, 48:285-296. 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8, 10976634.
171. Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, Gensert J, Chavez J. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 2004, 35:2687-2689. 10.1161/01.STR.0000143216.85349.9e, 15472113.
172. Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 2004, 1:26-35. 10.1602/neurorx.1.1.26, 534910, 15717005.
173. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 2006, 21:18-28. 10.1016/j.nbd.2005.06.002, 16040250.
174. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 2005, 36:2781-2790. 10.1161/01.STR.0000189996.71237.f7, 16254221.
175. Tauskela JS, chakravarthy BR, Murray CL, Wang Y, Comas T, Hogan M, Hakim A, Morley P. Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res 1999, 827:143-151. 10.1016/S0006-8993(99)01322-0, 10320703.
176. Perez-Pinzon MA, Born JG. Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience 1999, 89:453-459. 10.1016/S0306-4522(98)00560-0, 10077327.
177. Raval AP, Dave KR, Mochly-Rosen D, Sick TJ, Perez-Pinzon MA. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci 2003, 23:384-391.
178. Lange-Asschenfeldt C, Raval AP, Dave KR, Mochly-Rosen D, Sick TJ, Perez-Pinzon MA. Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J Cereb Blood Flow Metab 2004, 24:636-645. 10.1097/01.WCB.0000121235.42748.BF, 15181371.
179. Tauskela JS, Comas T, Hewitt K, Monette R, Paris J, Hogan M, Morley P. Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures. Neuroscience 2001, 107:571-584. 10.1016/S0306-4522(01)00381-5, 11720781.
180. Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol 1999, 380:91-99. 10.1016/S0014-2999(99)00523-3, 10513567.
181. Wang RM, Yang F, Zhang YX. Preconditioning-induced activation of ERK5 is dependent on moderate Ca2+ influx via NMDA receptors and contributes to ischemic tolerance in the hippocampal CA1 region of rats. Life Sci 2006, 79:1839-1846. 10.1016/j.lfs.2006.06.041, 16859717.
182. Duszczyk M, Gadamski R, Ziembowicz A, Danysz W, Lazarewicz JW. NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo. Neurotox Res 2005, 7:283-292. 10.1007/BF03033886, 16179265.
183. Lange-Asschenfeldt C, Raval AP, Perez-Pinzon MA. Ischemic tolerance induction in organotypic hippocampal slices: role for the GABA(A) receptor?. Neurosci Lett 2005, 384:87-92. 10.1016/j.neulet.2005.04.053, 15908115.
184. Tauskela JS, Morley P. On the role of Ca2+ in cerebral ischemic preconditioning. Cell Calcium 2004, 36:313-322. 10.1016/j.ceca.2004.02.008, 15261487.
185. Pong K. Ischaemic preconditioning: therapeutic implications for stroke?. Expert Opin Ther Targets 2004, 8:125-139. 10.1517/14728222.8.2.125, 15102554.
186. Rodrigo GC, Standen NB. ATP-sensitive potassium channels. Curr Pharm Des 2005, 11:1915-1940. 10.2174/1381612054021015, 15974968.
187. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 1995, 92:4666-4670. 10.1073/pnas.92.10.4666, 42005, 7753861.
188. Reshef A, Sperling O, Zoref-Shani E. Opening of K(ATP) channels is mandatory for acquisition of ischemic tolerance by adenosine. Neuroreport 2000, 11:463-465. 10.1097/00001756-200002280-00007, 10718295.
189. Hiraide T, Katsura K, Muramatsu H, Asano G, Katayama Y. Adenosine receptor antagonists cancelled the ischemic tolerance phenomenon in gerbil. Brain Res 2001, 910:94-98. 10.1016/S0006-8993(01)02647-6, 11489258.
190. Yoshida M, Nakakimura K, Cui YJ, Matsumoto M, Sakabe T. Adenosine A(1) receptor antagonist and mitochondrial ATP-sensitive potassium channel blocker attenuate the tolerance to focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2004, 24:771-779. 10.1097/01.WCB.0000122742.72175.1B, 15241185.
191. Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW. Cortical spreading depression (CSD)-induced tolerance to transient focal cerebral ischemia in halothane anesthetized rats is affected by anesthetic level but not ATP-sensitive potassium channels. Brain Res 2005, 1062:127-133. 10.1016/j.brainres.2005.09.010, 16256083.
192. Nandagopal K, Dawson TM, Dawson VL. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 2001, 297:474-478.
193. Huang PL. Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 2004, 36:323-329. 10.1016/j.ceca.2004.02.007, 15261488.
194. Puisieux F, Deplanque D, Pu Q, Souil E, Bastide M, Bordet R. Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance. Eur J Pharmacol 2000, 389:71-78. 10.1016/S0014-2999(99)00893-6, 10686298.
195. Zimmermann C, Ginis I, Furuya K, Klimanis D, Ruetzler C, Spatz M, Hallenbeck JM. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 2001, 895:59-65. 10.1016/S0006-8993(01)02028-5, 11259760.
196. Lastres-Becker I, Cartmell T, Molina-Holgado F. Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J Neuroimmunol 2006, 173:108-116. 10.1016/j.jneuroim.2005.12.006, 16439029.
197. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J Cereb Blood Flow Metab 1996, 16:1137-1142. 10.1097/00004647-199611000-00007, 8898685.
198. Cardenas A, Moro MA, Leza JC, O'Shea E, Davalos A, Castillo J, Lorenzo P, Lizasoain I. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab 2002, 22:1297-1302. 10.1097/00004647-200211000-00002, 12439286.
199. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, Jackson DB, Joberty G, Neubauer G, Rick J, Kuster B, Superti-Furga G. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004, 6:97-105. 10.1038/ncb1086, 14743216.
200. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001, 21:4668-4677.
201. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647. 10.1038/35088074, 11493922.
202. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009, 158:1007-1020. 10.1016/j.neuroscience.2008.07.067, 18809468.
203. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286:1358-1362. 10.1126/science.286.5443.1358, 10558990.
204. Miao B, Yin XH, Pei DS, Zhang QG, Zhang GY. Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-methyl-D-aspartate receptor-mediated Akt1 activation. J Biol Chem 2005, 280:21693-21699. 10.1074/jbc.M500003200, 15797868.
205. Zhang Y, Park TS, Gidday JM. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol 2007, 292:H2573-2581. 10.1152/ajpheart.01098.2006, 17337592.
206. Nakajima T, Iwabuchi S, Miyazaki H, Okuma Y, Kuwabara M, Nomura Y, Kawahara K. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J Vet Med Sci 2004, 66:521-527. 10.1292/jvms.66.521, 15187362.
207. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003, 362:1028-1037. 10.1016/S0140-6736(03)14412-1, 14522533.
208. Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of preconditioning. Stroke 2004, 35:2683-2686. 10.1161/01.STR.0000143735.89281.bb, 15459430.
209. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 2007, 38:680-685. 10.1161/01.STR.0000251444.56487.4c, 17261715.
210. Stevens SL, Stenzel-Poore MP. Toll-like receptors and tolerance to ischaemic injury in the brain. Biochem Soc Trans 2006, 34:1352-1355. 10.1042/BST0340492, 17073817.
211. Nakamura M, Nakakimura K, Matsumoto M, Sakabe T. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. J Cereb Blood Flow Metab 2002, 22:161-170. 10.1097/00004647-200202000-00004, 11823714.
212. Truettner J, Busto R, Zhao W, Ginsberg MD, Perez-Pinzon MA. Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain. Brain Res Mol Brain Res 2002, 103:106-115. 10.1016/S0169-328X(02)00191-2, 12106696.
213. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 2004, 24:1288-1304. 10.1097/01.WCB.0000145666.68576.71, 15545925.
214. Pera J, Zawadzka M, Kaminska B, Szczudlik A. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J Neurosci Res 2004, 78:132-140. 10.1002/jnr.20232, 15372497.
215. Pera J, Zawadzka M, Kaminska B, Szczudlik A. Neurotrophic factor expression after focal brain ischemia preceded by different preconditioning strategies. Cerebrovasc Dis 2005, 19:247-252. 10.1159/000084088, 15731555.
216. Nyitrai G, Puskas L, Antal K, Takacs V, Sass M, Juhasz G, Kardos J, Palkovits M. Preconditioning-specific reduction of c-fos expression in hippocampal granule and pyramidal but not other forebrain neurons of ischemic brain: a quantitative immunohistochemical study. Neurosci Lett 2005, 381:344-349. 10.1016/j.neulet.2005.02.045, 15896497.
217. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998, 29:159-165.
218. Gibson CL, Gray LJ, Murphy SP, Bath PM. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 2006, 26:1103-1113.
219. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 2003, 177:459-466. 10.1046/j.1365-201X.2003.01068.x, 12648163.
220. Wang C, Chiari PC, Weihrauch D, Krolikowski JG, Warltier DC, Kersten JR, Pratt PF, Pagel PS. Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase. Anesth Analg 2006, 103:274-280. 10.1213/01.ANE.0000230389.76351.0C, 16861402.
221. Kitano H, Young JM, Cheng J, Wang L, Hurn PD, Murphy SJ. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J Cereb Blood Flow Metab 2007, 27:1377-1386. 10.1038/sj.jcbfm.9600444, 2266686, 17264860.
222. Dowden J, Corbett D. Ischemic preconditioning in 18- to 20-month-old gerbils: long-term survival with functional outcome measures. Stroke 1999, 30:1240-1246.
223. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res 2005, 2:365-374. 10.2174/156720205774962674, 16375718.
224. Della Morte D, Abete P, Gallucci F, Scaglione A, D'Ambrosio D, Gargiulo G, De Rosa G, Dave KR, Lin HW, Cacciatore F, Mazzella F, Uomo G, Rundek T, Perez-Pinzon MA, Rengo F. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J Stroke Cerebrovasc Dis 2008, 17:257-262. 10.1016/j.jstrokecerebrovasdis.2008.03.004, 2676578, 18755403.
225. Tomida S, Nowak TS, Vass K, Lohr JM, Klatzo I. Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J Cereb Blood Flow Metab 1987, 7:773-782.
226. Pugliese AM, Latini S, Corradetti R, Pedata F. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br J Pharmacol 2003, 140:305-314. 10.1038/sj.bjp.0705442, 1574038, 12970092.
227. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res 2007, 1152:228-233. 10.1016/j.brainres.2007.03.068, 17475225.
228. Shen YT, Depre C, Yan L, Park JY, Tian B, Jain K, Chen L, Zhang Y, Kudej RK, Zhao X, Sadoshima J, Vatner DE, Vatner SF. Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation 2008, 118:1961-1969. 10.1161/CIRCULATIONAHA.108.788240, 2634862, 18936329.
229. Ohno M, Watanabe S. Ischemic tolerance to memory impairment associated with hippocampal neuronal damage after transient cerebral ischemia in rats. Brain Res Bull 1996, 40:229-236. 10.1016/0361-9230(96)00050-0, 8736585.
230. Shamloo M, Wieloch T. Changes in protein tyrosine phosphorylation in the rat brain after cerebral ischemia in a model of ischemic tolerance. J Cereb Blood Flow Metab 1999, 19:173-183. 10.1097/00004647-199902000-00009, 10027773.
231. Sommer C. Neuronal plasticity after ischemic preconditioning and TIA-like preconditioning ischemic periods. Acta Neuropathol 2009, 117:511-523. 10.1007/s00401-008-0473-0, 19084975.
232. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, Einhaupl KM. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?. Stroke 1999, 30:1851-1854.
233. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci Lett 2005, 377:206-211. 10.1016/j.neulet.2004.12.004, 15755527.
234. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect?. Neurology 2000, 54:2089-2094.
235. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 2004, 35:2680-2682. 10.1161/01.STR.0000143322.20491.0f, 15388902.
236. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehulsing GJ, Brunecker P, Muller B, Banasik A, Amberger N, Wernecke KD, Siebler M, Röther J, Villringer A, Weih M, . MRI in Acute Stroke Study Group of the German Competence Network Stroke Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004, 35:616-621. 10.1161/01.STR.0000115767.17923.6A, 14963288, MRI in Acute Stroke Study Group of the German Competence Network Stroke.
237. Steiger HJ, Hanggi D. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) 2007, 149:1-10. 10.1007/s00701-006-1057-1, 17151832.
238. Caplan LR. Do transient ischemic attacks have a neuroprotective effect?. Neurology 2000, 55:1596.
239. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 2009, 8:398-412. 10.1016/S1474-4422(09)70054-7, 2668955, 19296922.
240. Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Davalos A. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol 2003, 54:811-819. 10.1002/ana.10765, 14681891.
241. Laskey WK, Beach D. Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention. J Am Coll Cardiol 2003, 42:998-1003. 10.1016/S0735-1097(03)00909-4, 13678919.
242. Jneid H, Leessar M, Bolli R. Cardiac preconditioning during percutaneous coronary interventions. Cardiovasc Drugs Ther 2005, 19:211-217. 10.1007/s10557-005-2466-8, 16142599.